Internal Medicine, Gastroenterology · Rome, GA
NPI
1932269453
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1825 Martha Berry Blvd NW
Rome, GA, 30165
Phone (706) 295-5331
Groups this clinician bills Medicare through
Medicare paid, 2024
$161K
2,272 services
Medicare patients, 2024
941
Average age 73
Drug cost, 2024
$1.7M
3,639 prescriptions
Company payments, 2025
$35.96
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen F Finn was code 99213 (office e&m - established), 280 times for 255 patients. In total Stephen F Finn billed 2,272 services in 83 codes, and Medicare paid $161K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 280 | 255 | $54.94 | $15K |
| 36415 Venipuncture Blood Collection | Office | 225 | 149 | $8.44 | $1,899 |
| 45385 Colonoscopy - Lesion Removal | Facility | 189 | 189 | $196.55 | $37K |
| 85025 Blood Count | Office | 179 | 119 | $7.39 | $1,324 |
| 99214 Office E&M - Established | Office | 149 | 141 | $78.02 | $12K |
| 43235 Upper GI Endoscopy | Facility | 117 | 114 | $80.50 | $9,418 |
| 99222 Hospital E&M - Initial | Facility | 102 | 100 | $94.21 | $9,610 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 100 | 100 | $171.44 | $17K |
| 43239 Upper GI Endoscopy | Facility | 85 | 81 | $87.61 | $7,447 |
| 80053 Clinical Chemistry | Office | 84 | 61 | $10.09 | $848 |
| 43450 Digestive/Gastrointestinal | Facility | 70 | 69 | $39.82 | $2,788 |
| 99215 Office E&M - Established | Office | 63 | 60 | $120.15 | $7,569 |
| 45378 Lower GI Endoscopy - Other | Facility | 52 | 51 | $122.24 | $6,356 |
| 85610 Clinical Chemistry | Office | 50 | 36 | $4.13 | $206 |
| 45380 Lower GI Endoscopy - Other | Facility | 47 | 47 | $89.11 | $4,188 |
By year: 2022 $210K for 2,945 services; 2023 $164K for 2,111 services; 2024 $161K for 2,272 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 225 | 149 | $8.44 | $1,899 |
| 85025 Blood Count | 179 | 119 | $7.39 | $1,324 |
| 80053 Clinical Chemistry | 84 | 61 | $10.09 | $848 |
| 85610 Clinical Chemistry | 50 | 36 | $4.13 | $206 |
| 82728 Clinical Chemistry | 45 | 39 | $13.36 | $601 |
| 83540 Clinical Chemistry | 30 | 26 | $6.34 | $190 |
| 83550 Clinical Chemistry | 30 | 26 | $8.57 | $257 |
| 82565 Clinical Chemistry | 26 | 26 | $5.02 | $131 |
| 80076 Clinical Chemistry | 16 | 13 | $8.01 | $128 |
| 84520 Clinical Chemistry | 12 | 12 | $3.87 | $46.44 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephen F Finn prescribed most often to Medicare patients was Omeprazole, with 680 prescriptions and refills. In total Stephen F Finn wrote 3,639 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 680 | 1,780 | 249 | $10K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 457 | 457 | 445 | $6,935 |
| Famotidine Generic | 311 | 782 | 116 | $4,677 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 231 | 231 | 219 | $3,781 |
| Dicyclomine Hcl Generic | 207 | 250 | 76 | $4,622 |
| Pantoprazole Sodium Generic | 203 | 481 | 76 | $2,545 |
| Metronidazole Generic | 191 | 191 | 167 | $1,320 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 128 | 128 | 126 | $2,250 |
| Colestipol Hcl Generic | 124 | 234 | 46 | $19K |
| Ondansetron Odt Ondansetron | 81 | 89 | 34 | $1,176 |
| Linzess Linaclotide | 74 | 129 | 26 | $68K |
| Esomeprazole Magnesium Generic | 71 | 194 | 23 | $2,225 |
| Nortriptyline Hcl Generic | 51 | 107 | Under 11 | $1,284 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 49 | 49 | 46 | $1,183 |
| Sucralfate Generic | 48 | 51 | 23 | $3,147 |
Brand drugs: 550 claims; generic drugs: 3,089 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen F Finn $35.96 ($35.96 in general payments such as food, travel and fees) from 1 company. The largest payer was Boston Scientific Corporation with $35.96.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 1 | $35.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.